{"pmid":32485316,"pmcid":"PMC7260530","title":"Pentoxifylline and complicated COVID-19: A pathophysiologically based treatment proposal.","text":["Pentoxifylline and complicated COVID-19: A pathophysiologically based treatment proposal.","Med Hypotheses","Assimakopoulos, Stelios F","Seintis, Fotios","Marangos, Markos","32485316"],"journal":"Med Hypotheses","authors":["Assimakopoulos, Stelios F","Seintis, Fotios","Marangos, Markos"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32485316","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.mehy.2020.109926","e_drugs":["Pentoxifylline"],"topics":["Treatment"],"weight":1,"_version_":1668704334391541761,"score":9.490897,"similar":[{"pmid":32449676,"title":"COVID-19: Pentoxifylline as a potential adjuvant treatment.","text":["COVID-19: Pentoxifylline as a potential adjuvant treatment.","Int J Clin Pharmacol Ther","Feily, Amir","Daneshpay, Kian","Alighadr, Arash","32449676"],"journal":"Int J Clin Pharmacol Ther","authors":["Feily, Amir","Daneshpay, Kian","Alighadr, Arash"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32449676","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.5414/CP203782","e_drugs":["Pentoxifylline"],"topics":["Treatment"],"weight":1,"_version_":1667785213940334592,"score":49.114235},{"pmid":32473070,"title":"Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?","text":["Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?","The world is facing a viral pandemic of a new coronavirus called COVID-19. Pentoxifylline is a methyl-xanthine and it inhibits phosphodiesterase IV (PDE IV). This drug is known for its unique features as an immunomodulatory and anti-inflammatory agent, also it could have antiviral affects. This is a scoping review, in which all related articles on COVID-19 and the probable benefits of Pentoxifylline against COVID-19 pathogenesis, in Medline, Scopus, Web of Sciences and Google Scholar up to March 20, 2020 with proper keywords including: pentoxifylline, Pentoxil, COVID-19, coronavirus, treatment, anti-inflammatory, immunomodulatory, anti-fibrosis, oxygenation, circulation, bronchodilator, ARDS and organ failure. We found many confirmatory data on proper efficacy of pentoxifylline n controlling COVID-19 and its consequences. The antiviral, anti-inflammatory, anti-oxidative, immune-modulatory, bronchodilator and respiratory supportive effects and protective roles in organ failures of PTX, along with its main functions means better circulation-oxygenation properties, low price and safety, make it a promising drug to be considered for covid-19 treatment, especially as an adjuvant therapy in combination with other drugs. This article is protected by copyright. All rights reserved.","Dermatol Ther","Seirafianpour, Farnoosh","Mozafarpoor, Samaneh","Fattahi, Nima","Sadeghzadeh-Bazargan, Afsaneh","Hanifiha, Melika","Goodarzi, Azadeh","32473070"],"abstract":["The world is facing a viral pandemic of a new coronavirus called COVID-19. Pentoxifylline is a methyl-xanthine and it inhibits phosphodiesterase IV (PDE IV). This drug is known for its unique features as an immunomodulatory and anti-inflammatory agent, also it could have antiviral affects. This is a scoping review, in which all related articles on COVID-19 and the probable benefits of Pentoxifylline against COVID-19 pathogenesis, in Medline, Scopus, Web of Sciences and Google Scholar up to March 20, 2020 with proper keywords including: pentoxifylline, Pentoxil, COVID-19, coronavirus, treatment, anti-inflammatory, immunomodulatory, anti-fibrosis, oxygenation, circulation, bronchodilator, ARDS and organ failure. We found many confirmatory data on proper efficacy of pentoxifylline n controlling COVID-19 and its consequences. The antiviral, anti-inflammatory, anti-oxidative, immune-modulatory, bronchodilator and respiratory supportive effects and protective roles in organ failures of PTX, along with its main functions means better circulation-oxygenation properties, low price and safety, make it a promising drug to be considered for covid-19 treatment, especially as an adjuvant therapy in combination with other drugs. This article is protected by copyright. All rights reserved."],"journal":"Dermatol Ther","authors":["Seirafianpour, Farnoosh","Mozafarpoor, Samaneh","Fattahi, Nima","Sadeghzadeh-Bazargan, Afsaneh","Hanifiha, Melika","Goodarzi, Azadeh"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32473070","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/dth.13733","keywords":["ards (acute respiratory distress syndrome)","covid-19","pentoxil","sars (severe acute respiratory syndrome)","anti-fibrosis","anti-inflammatory","anti-oxidant","apoptosis-regulatory","bronchodilator","coronavirus","immunomodulatory","oxygenation","pentoxifylline","perfusion","review","treatment"],"locations":["Medline","Scopus"],"topics":["Treatment"],"weight":1,"_version_":1668255193285787648,"score":48.173798}]}